UCB SA UCBJF
317.00 USD +0.59 (+0.19%)
At closeOct 30, 2026, 4:00 PM EDT
317.00 Day range 317.00
219.60 52-week range 345.39
- YTD
- +7.98%
- 1 year
- +19.19%
- Market cap
- 60.44B
- EPS (ttm)
- 13.20
- P/E ratio
- 24.02
- YTD return
- +7.98%
- 1-year return
- +19.19%
- Volume
- 3
- Avg volume
- 454
- Open
- 317.00
- Previous close
- 316.41
- Day's range
- 317.00 – 317.00
- 52-week range
- 219.60 – 345.39
- Earnings date
- Feb 25, 2027
YTD +30.93 (+10.93%)
Next earnings
Feb 25, 2027
Expected Feb 25, 2027. Consensus EPS estimate 6.05.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 25, 2027 | Dec 30, 2026 | 6.05 | — | — | — |
| Jul 30, 2026 | Jun 30, 2026 | 5.81 | 7.81 | +2.00 | +34.42% |
| Feb 26, 2026 | Dec 31, 2025 | 5.83 | 7.59 | +1.76 | +30.19% |
| Jul 31, 2025 | Jun 30, 2025 | 3.89 | 2.88 | -1.01 | -25.96% |
| Feb 27, 2025 | Dec 31, 2024 | 2.68 | 4.56 | +1.88 | +70.15% |
| Jul 25, 2024 | Jun 30, 2024 | 1.89 | 1.15 | -0.74 | -39.15% |
News
Are You Looking for a Top Momentum Pick? Why United Community Banks (UCB) is a Great Choice 
What's Going On with MoonLake Immunotherapeutics Stock on Thursday? 
United Community Banks (UCB) Upgraded to Strong Buy: Here's What You Should Know 
UCB Shares Jump After Demand for Immunology Drug Bimzelx Boosts Outlook 
United Community Banks, Inc. (UCB) Q3 2026 Earnings Call Transcript 
What United Community Banks (UCB) Said on Its Q3 Earnings Call 
United Community Banks (UCB) Reports Q3 Earnings: What Key Metrics Have to Say 
United Community Banks (UCB) Q3 Earnings Match Estimates 
United Community Banks (UCB) Reports Next Week: Wall Street Expects Earnings Growth 
UCB SA (UCBJY) Discusses EADV Data Highlights and Long-Term Impact of BIMZELX in Dermatology Transcript
Your note
Sign in to keep a note on UCBJF — it syncs with the Stock Master app.